Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Common Equity (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Common Equity for 16 consecutive years, with $393.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity rose 16.67% to $393.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $393.5 million, a 16.67% increase, with the full-year FY2025 number at $393.5 million, up 16.67% from a year prior.
  • Common Equity was $393.5 million for Q4 2025 at Lemaitre Vascular, up from $378.9 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $393.5 million in Q4 2025 to a low of $177.5 million in Q1 2021.
  • A 5-year average of $291.8 million and a median of $286.2 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: surged 54.7% in 2021, then increased 4.9% in 2022.
  • Lemaitre Vascular's Common Equity stood at $254.2 million in 2021, then grew by 5.53% to $268.2 million in 2022, then grew by 11.07% to $297.9 million in 2023, then grew by 13.22% to $337.3 million in 2024, then grew by 16.67% to $393.5 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Common Equity are $393.5 million (Q4 2025), $378.9 million (Q3 2025), and $362.7 million (Q2 2025).